Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||
| Net Income | -11,224 | 17,124 |
| Depreciation Amortization | 25,370 | 15,643 |
| Income taxes - deferred | -887 | 8,625 |
| Accounts receivable | -1,114 | -3,333 |
| Accounts payable and accrued liabilities | -1,141 | -2,374 |
| Other Working Capital | -9,399 | -2,922 |
| Other Operating Activity | 32,163 | 4,805 |
| Operating Cash Flow | $33,768 | $37,568 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -15,565 | -11,091 |
| Net Acquisitions | 989 | -23,892 |
| Other Investing Activity | 0 | 815 |
| Investing Cash Flow | $-14,576 | $-34,168 |
| Cash Flows From Financing Activities | ||
| Debt Issued | N/A | 339,007 |
| Debt Repayment | -202,956 | -1,479 |
| Common Stock Issued | 235,964 | 102,993 |
| Other Financing Activity | -32,226 | -452,025 |
| Financing Cash Flow | $782 | $-11,504 |
| Exchange Rate Effect | -1,855 | -1,697 |
| Beginning Cash Position | 15,010 | 24,811 |
| End Cash Position | 33,129 | 15,010 |
| Net Cash Flow | $18,119 | $-9,801 |
| Free Cash Flow | ||
| Operating Cash Flow | 33,768 | 37,568 |
| Capital Expenditure | -15,565 | -12,951 |
| Free Cash Flow | 18,203 | 24,617 |